ArticleBritish journal of cancer2022

Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer.

Hugh A Nicholson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.